Wikidata |

Wikidata

Matches in Wikidata for { <http://www.wikidata.org/entity/Q37662391> ?p ?o ?g. }

Showing items 1 to 100 of ±110 with 100 items per page.

Q37662391 description "article científic" @default.
Q37662391 description "article scientifique" @default.
Q37662391 description "articolo scientifico" @default.
Q37662391 description "artigo científico" @default.
Q37662391 description "artículu científicu espublizáu en 2016" @default.
Q37662391 description "bilimsel makale" @default.
Q37662391 description "scientific article published on 31 August 2016" @default.
Q37662391 description "vedecký článok" @default.
Q37662391 description "vetenskaplig artikel" @default.
Q37662391 description "videnskabelig artikel" @default.
Q37662391 description "vědecký článek" @default.
Q37662391 description "wetenschappelijk artikel" @default.
Q37662391 description "wissenschaftlicher Artikel" @default.
Q37662391 description "наукова стаття, опублікована в серпні 2016" @default.
Q37662391 description "научни чланак" @default.
Q37662391 description "مقالة علمية نشرت في 31 أغسطس 2016" @default.
Q37662391 name "Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide GP2 vaccine in breast cancer patients to prevent recurrence" @default.
Q37662391 name "Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide GP2 vaccine in breast cancer patients to prevent recurrence" @default.
Q37662391 name "Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide GP2 vaccine in breast cancer patients to prevent recurrence" @default.
Q37662391 type Item @default.
Q37662391 label "Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide GP2 vaccine in breast cancer patients to prevent recurrence" @default.
Q37662391 label "Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide GP2 vaccine in breast cancer patients to prevent recurrence" @default.
Q37662391 label "Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide GP2 vaccine in breast cancer patients to prevent recurrence" @default.
Q37662391 prefLabel "Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide GP2 vaccine in breast cancer patients to prevent recurrence" @default.
Q37662391 prefLabel "Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide GP2 vaccine in breast cancer patients to prevent recurrence" @default.
Q37662391 prefLabel "Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide GP2 vaccine in breast cancer patients to prevent recurrence" @default.
Q37662391 P1433 Q37662391-41B683F5-C88D-4C5F-AA97-BAE73B7034E4 @default.
Q37662391 P1476 Q37662391-DF096B88-31D8-4851-B0DB-36A210B7E04B @default.
Q37662391 P2093 Q37662391-1E45BBD1-9679-418A-B62B-A3F5C3D07171 @default.
Q37662391 P2093 Q37662391-28F9174F-FCC5-4254-A23A-9C9F81983BDD @default.
Q37662391 P2093 Q37662391-4BB9B766-F9C7-4122-8598-4110D7E1A8BF @default.
Q37662391 P2093 Q37662391-5EDD4803-1B55-4C6C-8A4B-7BCFBD60FF72 @default.
Q37662391 P2093 Q37662391-A7F2C121-D894-47ED-AFB5-773ECBE2AAE7 @default.
Q37662391 P2093 Q37662391-BF4B07BB-D9AB-4B8E-A0D9-DB898BC234AE @default.
Q37662391 P2093 Q37662391-CB0B4868-A9BB-473F-8CD7-8A9F86367D80 @default.
Q37662391 P2093 Q37662391-D8BEB38C-606E-4F75-A4F5-5913EA441215 @default.
Q37662391 P2093 Q37662391-E835E78F-674D-4C8F-8BB5-F0E3BDEEE9CB @default.
Q37662391 P2093 Q37662391-EE11BD9B-775B-4CE7-8CD0-E4CDB38B8BAD @default.
Q37662391 P2093 Q37662391-F1D47AFE-3896-4CE7-BD14-79DCED5D3396 @default.
Q37662391 P2860 Q37662391-0687C14E-7126-4E82-A279-7CAFBC3FA989 @default.
Q37662391 P2860 Q37662391-0B7FB395-0955-47C7-85B6-960983F1186D @default.
Q37662391 P2860 Q37662391-1057E7FB-946E-435A-ACE9-0D6164E03DA8 @default.
Q37662391 P2860 Q37662391-2D2BA749-187B-40B2-ABC9-F28A96012B8C @default.
Q37662391 P2860 Q37662391-384B9C3F-CF2D-4CAC-A3CA-D3BAE543CDEB @default.
Q37662391 P2860 Q37662391-3B40DF0C-F1D6-4DD4-B75F-BC9196AB91BD @default.
Q37662391 P2860 Q37662391-3FDC563F-2C55-442B-B69E-BB40D51C3AA7 @default.
Q37662391 P2860 Q37662391-487E157B-1168-47A5-B7D7-F2DBD0BF357F @default.
Q37662391 P2860 Q37662391-4EE6C3D8-C6C5-4D93-9F25-7105077DA882 @default.
Q37662391 P2860 Q37662391-6120AC7B-20A7-4983-9948-9F5030B968FD @default.
Q37662391 P2860 Q37662391-61F23205-DC4A-4FEC-96FD-75DC08E39D63 @default.
Q37662391 P2860 Q37662391-66FA8D15-6CC5-4EF4-8AC0-A3526F242ECD @default.
Q37662391 P2860 Q37662391-9B1596B1-10FF-42B2-AE5B-64EDE8321D88 @default.
Q37662391 P2860 Q37662391-A1967B00-A061-49F4-8AE2-E3F6D91291A0 @default.
Q37662391 P2860 Q37662391-A3839641-46F4-4863-8419-37C0DC6B1689 @default.
Q37662391 P2860 Q37662391-C9C25211-2F67-49D8-910B-6571EA8D56F9 @default.
Q37662391 P2860 Q37662391-D0A2F6C0-2D99-440D-9B76-DBFD9CFF3547 @default.
Q37662391 P2860 Q37662391-FABC860E-C6D3-4D0C-8AFF-D586C0437230 @default.
Q37662391 P304 Q37662391-8E187180-F693-4227-98CB-FF9813C2470F @default.
Q37662391 P31 Q37662391-5EADB994-3EF7-41A8-93E4-5E85EC8B7E7C @default.
Q37662391 P356 Q37662391-04002ADB-D689-44B1-BC1E-7E3C6A727126 @default.
Q37662391 P407 Q37662391-48F103CF-E07F-4C0E-869C-01E3136C5F28 @default.
Q37662391 P433 Q37662391-409D409B-02EE-4352-B1FC-8CFAD7B0B75C @default.
Q37662391 P478 Q37662391-EB2AD349-A082-4D9A-97B0-C04A8488357A @default.
Q37662391 P577 Q37662391-DBC9AC95-98D4-4A47-9323-E454E1D60659 @default.
Q37662391 P698 Q37662391-CEFB6792-6592-4165-8D9C-7CC6F2BB83BA @default.
Q37662391 P921 Q37662391-D2EFB1AA-02EF-4832-8909-3003591FDAB6 @default.
Q37662391 P932 Q37662391-01B4F0C7-5742-453B-B05F-AD494265751E @default.
Q37662391 P356 ONCOTARGET.11751 @default.
Q37662391 P698 27589688 @default.
Q37662391 P1433 Q1573155 @default.
Q37662391 P1476 "Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide GP2 vaccine in breast cancer patients to prevent recurrence" @default.
Q37662391 P2093 "Alexandros Ardavanis" @default.
Q37662391 P2093 "Constantin N Baxevanis" @default.
Q37662391 P2093 "Diane F Hale" @default.
Q37662391 P2093 "Elizabeth A Mittendorf" @default.
Q37662391 P2093 "George E Peoples" @default.
Q37662391 P2093 "James L Murray" @default.
Q37662391 P2093 "Jennifer K Litton" @default.
Q37662391 P2093 "Michael Papamichail" @default.
Q37662391 P2093 "Nathan M Shumway" @default.
Q37662391 P2093 "Sathibalan Ponniah" @default.
Q37662391 P2093 "Sonia A Perez" @default.
Q37662391 P2860 Q24611404 @default.
Q37662391 P2860 Q27620636 @default.
Q37662391 P2860 Q33928441 @default.
Q37662391 P2860 Q34083121 @default.
Q37662391 P2860 Q34138324 @default.
Q37662391 P2860 Q34194706 @default.
Q37662391 P2860 Q34765735 @default.
Q37662391 P2860 Q37041195 @default.
Q37662391 P2860 Q37369840 @default.
Q37662391 P2860 Q40741896 @default.
Q37662391 P2860 Q40823501 @default.
Q37662391 P2860 Q42798418 @default.
Q37662391 P2860 Q42799296 @default.
Q37662391 P2860 Q43775674 @default.
Q37662391 P2860 Q51798935 @default.
Q37662391 P2860 Q71189323 @default.
Q37662391 P2860 Q81038993 @default.
Q37662391 P2860 Q83095982 @default.